![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1620, 2008-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
High-Dose Chemotherapy in Breast Cancer
By Lake Diana E. Hudis Clifford A.
Drugs, Vol. 64, Iss. 17, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Lower costs with sequential high-dose chemotherapy in breast cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 422, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
High-dose chemotherapy regimen well tolerated in breast cancer
Inpharma, Vol. 1, Iss. 1320, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
High-dose torasemide vs furosemide for refractory CHF
Inpharma, Vol. 1, Iss. 1486, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Low- vs high-dose cyclophosphamide in lupus nephritis
Inpharma, Vol. 1, Iss. 1359, 2002-01 ,pp. :